Posts Feed
Comments Feed

Archive for the 'Cholesterol' Category

Crestor Can Reduce Risk For Cardiovascular Events In Patients With High Levels Of Protein, Study Finds

Nov 21st 2008Drug InformationCholesterol

The cholesterol medication Crestor, manufactured by AstraZeneca, can reduce by about half the risk for heart attack, stroke and death among patients who do not have high cholesterol levels but tested positive for high levels of a protein linked with increased risk for heart attack, according to a study presented Sunday at the annual meeting of the

More: continued here

No Comments »

Statin Reduces Heart Attack, Stroke Rates In Patients With Normal Cholesterol But Elevated C-Reactive Protein

Nov 21st 2008Drug InformationCholesterol

New data from the landmark ATHENA trial showed that dronedarone significantly reduced the incidence and total duration of hospital stays among patients with atrial fibrillation/atrial flutter (AF/AFL). This post-hoc analysis was presented at the 2008 American Heart Association Scientific Sessions in New Orleans, Louisiana. In this new analysis, dronedarone significantly reduced the total number of hospital days by 28 percent (p

More: continued here

No Comments »

Atherotech To Exhibit VAP(R) Cholesterol Test At American Heart Association Scientific Sessions 2008

Nov 7th 2008Drug InformationCholesterol

Atherotech, Inc., a cardio-diagnostic company, today announced it will be exhibiting its VAP(R) Cholesterol Test in booth No. 2918 at the American Heart Association Scientific Sessions 2008. The annual meeting takes place Nov. 8-12 at the Ernest N. Morial Convention Center in New Orleans. Atherotech representatives will be available to discuss the VAP Cholesterol Test during regular exhibit hours on October 9, 10 and 11 in booth No.

More: continued here

No Comments »

« Prev - Next »

1